No association of graft-versus-host disease with decreased relapse rate in lymphoma in myeloablative cases was observed
Graft-versus-host disease decreases the relapse rate in follicular and mantle lymphoma in reduced-intensity transplantations
Despite decreasing relapse, graft-versus-host disease has a deleterious effect on clinical outcome